LLY

804.39

-0.47%↓

UNH

542.54

-0.15%↓

JNJ

150.62

-1.47%↓

ABBV

174.84

-1.17%↓

NVO

84.94

-2.85%↓

LLY

804.39

-0.47%↓

UNH

542.54

-0.15%↓

JNJ

150.62

-1.47%↓

ABBV

174.84

-1.17%↓

NVO

84.94

-2.85%↓

LLY

804.39

-0.47%↓

UNH

542.54

-0.15%↓

JNJ

150.62

-1.47%↓

ABBV

174.84

-1.17%↓

NVO

84.94

-2.85%↓

LLY

804.39

-0.47%↓

UNH

542.54

-0.15%↓

JNJ

150.62

-1.47%↓

ABBV

174.84

-1.17%↓

NVO

84.94

-2.85%↓

LLY

804.39

-0.47%↓

UNH

542.54

-0.15%↓

JNJ

150.62

-1.47%↓

ABBV

174.84

-1.17%↓

NVO

84.94

-2.85%↓

Search

Travere Therapeutics Inc

Closed

20.99 5.21

Overview

Share price change

24h

Current

Min

19.82

Max

21.35

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+39.99 upside

Dividends

By Dow Jones

Next Earnings

13 Feb 2025

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Travere Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

27 Jan 2025, 22:42 UTC

Acquisitions, Mergers, Takeovers

Fortescue Launches All-Cash Takeover of Australia's Red Hawk

27 Jan 2025, 21:33 UTC

Top News

Canadian Pacific Kansas City Reaches Four-Year Tentative Agreement with Unifor

27 Jan 2025, 23:44 UTC

Market Talk

Nikkei May Fall After U.S. Tech Selloff -- Market Talk

27 Jan 2025, 22:46 UTC

Market Talk

Nucor Sees 2024's Weak Steel Market Spilling Into 1Q -- Market Talk

27 Jan 2025, 22:45 UTC

Top News

McDonald's U.S. Marketing Chief Steps Down -- WSJ

27 Jan 2025, 22:39 UTC

Market Talk

Whole Foods CEO Takes on Bigger Role in Amazon's Grocery Business -- Market Talk

27 Jan 2025, 22:38 UTC

Top News

Boeing Had Bad News About Earnings. More Details Come on Tuesday. -- Barrons.com

27 Jan 2025, 22:10 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Call Option Is on Same Pricing Terms as Offer

27 Jan 2025, 22:10 UTC

Acquisitions, Mergers, Takeovers

Fortescue Subsidiary Has Call Option Over 19.99% of Red Hawk Shares Held by TIO, OCJ Investment

27 Jan 2025, 22:10 UTC

Top News

RTX Earnings Are Coming. Can They Top GE? -- Barrons.com

27 Jan 2025, 22:08 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Red Hawk Board Unanimously Recommends Offers

27 Jan 2025, 22:07 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Independent Expert Judged Offer to Be Fair and Reasonable

27 Jan 2025, 22:07 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Proposal Is Via an Off-Market Takeover Bid

27 Jan 2025, 21:58 UTC

Market Talk

Global Energy Roundup: Market Talk

27 Jan 2025, 21:58 UTC

Market Talk

Chinese Steel Output Curbs Could Trigger Short-lived Iron-Ore Price Rally -- Market Talk

27 Jan 2025, 21:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

27 Jan 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

27 Jan 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

27 Jan 2025, 21:46 UTC

Acquisitions, Mergers, Takeovers

U.S. Steel Stock Falls. Another Actor Enters the Merger Drama. -- Barrons.com

27 Jan 2025, 21:35 UTC

Market Talk

Synlait Bear Unmoved on Stock Call Despite Earnings Beat -- Market Talk

27 Jan 2025, 21:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 Jan 2025, 21:32 UTC

Market Talk

Genesis Energy Can Beat Annual Earnings Guidance -- Market Talk

27 Jan 2025, 21:30 UTC

Earnings

Nucor 4Q Steel Mills Total Shipments 5.65M Tons >NUE

27 Jan 2025, 21:30 UTC

Earnings

Nucor 4Q Total Tons Shipped to Outside Customers Up 2% >NUE

27 Jan 2025, 21:30 UTC

Earnings

Nucor 4Q Sales $7.08B >NUE

27 Jan 2025, 21:30 UTC

Earnings

Nucor 4Q Average Sales Price Per Ton Down 10% >NUE

27 Jan 2025, 21:30 UTC

Earnings

Nucor 4Q EPS $1.22 >NUE

27 Jan 2025, 21:30 UTC

Earnings

Nucor 4Q Net $287M >NUE

27 Jan 2025, 21:28 UTC

Top News

Nvidia Stock Sinks in AI Rout Sparked by China's DeepSeek -- WSJ

27 Jan 2025, 20:28 UTC

Market Talk

Oil Futures Lose Ground in Rocky Start to the Week -- Market Talk

Peer Comparison

Price change

Travere Therapeutics Inc Forecast

Price Target

By TipRanks

39.99% upside

12 Months Forecast

Average 28.18 USD  39.99%

High 45 USD

Low 20 USD

Based on 14 Wall Street analysts offering 12 month price targets forTravere Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

12

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

18.4525 / 20.26Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Weak Bullish Evidence

Financials

$